PaZ02: A Study of Pazopanib safety and tolerability in patients with advanced clear-cell renal cell carcinoma and Performance Status 2 (ECOG)

  • Gough, Rich (Principal Investigator)

Project Details

Short titlePaZ02: A Study of Pazopanib safety and tolerability in patients with advanced clear-cell renal cell carcinoma and Performance Status 2 (ECOG)
StatusFinished
Effective start/end date1/07/11 → 30/06/20

Funding

  • Glaxosmithkline